Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?

Affiliations

Editorial

Tarun Girotra et al. Ann Transl Med. 2019 Sep.

. 2019 Sep;7(Suppl 6):S214.

doi: 10.21037/atm.2019.08.84.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
RESTART Collaboration. RESTART Collaboration. Lancet. 2019 Jun 29;393(10191):2613-2623. doi: 10.1016/S0140-6736(19)30840-2. Epub 2019 May 22. Lancet. 2019. PMID: 31128924 Free PMC article. Clinical Trial.

1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 2019;139:e56-528. 10.1161/CIR.0000000000000659 - DOI - PubMed
1. Krishnamurthi RV, Moran AE, Forouzanfar MH, et al. The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study. Glob Heart 2014;9:101-6. 10.1016/j.gheart.2014.01.003 - DOI - PubMed
1. RESTART Collaboration Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet 2019;393:2613-23. 10.1016/S0140-6736(19)30840-2 - DOI - PMC - PubMed
1. Chen CJ, Ding D, Buell TJ, et al. Restarting antiplatelet therapy after spontaneous intracerebral hemorrhage: functional outcomes. Neurology 2018;91:e26-36. 10.1212/WNL.0000000000005742 - DOI - PMC - PubMed
1. Teo KC, Lau GKK, Mak RHY, et al. Antiplatelet resumption after antiplatelet-related intracerebral hemorrhage: a retrospective hospital-based study. World Neurosurg 2017;106:85-91. 10.1016/j.wneu.2017.06.015 - DOI - PubMed